UBS has downgraded its outlook on US equities to 'neutral' from 'attractive' amid ongoing market volatility and uncertainty following recent tariff agreements between the US and China. Despite this, UBS maintains a full strategic allocation to US stocks, expecting equities to rise over the next year, particularly in sectors like communications, technology, healthcare, and utilities.The firm anticipates that upcoming legal challenges to the Trump administration's tariffs could lead to significant reductions, potentially lowering the effective US tariff rate to around 15-20% by year-end. If tariffs remain unchanged, the impact on the US economy could resemble a 2% VAT hike, affecting growth and prices without triggering a recession.